CTNND1 and breast cancer: Accordingly, we detected a significant enrichment of FOXC2 occupancy on the p120-catenin promoter in all cell lines representing either endocrine resistant or basal A breast cancer subtypes, but not in endocrine sensitive MCF7 (Fig. 5d).